R&D Partner Content Structure-Based Drug Design Summit Returns This June With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design.
R&D Partner Content Returning for a 4th Year... GPCRs-Targeted Drug Discovery! Transforming the Discovery of Novel GPCR-Targeted Therapies
R&D Partner Content 2nd ESG in Life Sciences Summit Europe Mastering Life Science ESG Compliance & Strategic Impact in 2025
R&D Partner Content 6th GxP Cloud Compliance Summit 2025 Advancing AI Advancing AI Validation, Risk Management, and Cloud Security to Ensure GxP Cloud Compliance
R&D Partner Content Innovation in Psychosis Therapeutics Summit Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.